5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one → 5-(8-(5-(Hydroxymethyl)thiazol-2-ylamino)imidazo[1,2-a]pyrazin-5-yl)isoindolin-1-one
반응식
[Br:1][c:2]1[cH:3][n:4][c:5]([NH:11][c:12]2[s:13][c:14]([CH2:17][OH:18])[cH:15][n:16]2)[c:6]2[n:7]1[cH:8][cH:9][n:10]2.[CH3:19][C:20]1([CH3:21])[C:22]([CH3:23])([CH3:24])[O:25][B:26]([c:27]2[cH:28][c:29]3[c:33]([cH:34][cH:35]2)[C:32](=[O:36])[NH:31][CH2:30]3)[O:37]1>>[c:2]1(-[c:27]2[cH:28][c:29]3[c:33]([cH:34][cH:35]2)[C:32](=[O:36])[NH:31][CH2:30]3)[cH:3][n:4][c:5]([NH:11][c:12]2[s:13][c:14]([CH2:17][OH:18])[cH:15][n:16]2)[c:6]2[n:7]1[cH:8][cH:9][n:10]2참가 물질
3
출처 및 근거
- ORD 기록
- ord-546a4cb2afe04de0ace5b76fcb1a3583
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (2/10)
반응 노트
불러오는 중…